These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18220607)

  • 21. Loss of β-arrestin2 mediates pancreatic-islet dysfunction in mice.
    Zhang M; Zhu Y; Mu K; Li L; Lu J; Zhao J; Huang X; Wang C; Jia W
    Biochem Biophys Res Commun; 2013 Jun; 435(3):345-9. PubMed ID: 23660189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FoxO1 Plays an Important Role in Regulating β-Cell Compensation for Insulin Resistance in Male Mice.
    Zhang T; Kim DH; Xiao X; Lee S; Gong Z; Muzumdar R; Calabuig-Navarro V; Yamauchi J; Harashima H; Wang R; Bottino R; Alvarez-Perez JC; Garcia-Ocaña A; Gittes G; Dong HH
    Endocrinology; 2016 Mar; 157(3):1055-70. PubMed ID: 26727107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin constitutively secreted by beta-cells is necessary for glucose-stimulated insulin secretion.
    Srivastava S; Goren HJ
    Diabetes; 2003 Aug; 52(8):2049-56. PubMed ID: 12882922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The required beta cell research for improving treatment of type 2 diabetes.
    Thorens B
    J Intern Med; 2013 Sep; 274(3):203-14. PubMed ID: 23751050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. β-Cell glutamate signaling: Its role in incretin-induced insulin secretion.
    Yokoi N; Gheni G; Takahashi H; Seino S
    J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):38-43. PubMed ID: 27186354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance.
    Cavaghan MK; Ehrmann DA; Polonsky KS
    J Clin Invest; 2000 Aug; 106(3):329-33. PubMed ID: 10930434
    [No Abstract]   [Full Text] [Related]  

  • 27. PKCζ Is Essential for Pancreatic β-Cell Replication During Insulin Resistance by Regulating mTOR and Cyclin-D2.
    Lakshmipathi J; Alvarez-Perez JC; Rosselot C; Casinelli GP; Stamateris RE; Rausell-Palamos F; O'Donnell CP; Vasavada RC; Scott DK; Alonso LC; Garcia-Ocaña A
    Diabetes; 2016 May; 65(5):1283-96. PubMed ID: 26868297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes.
    Devedjian JC; George M; Casellas A; Pujol A; Visa J; Pelegrín M; Gros L; Bosch F
    J Clin Invest; 2000 Mar; 105(6):731-40. PubMed ID: 10727441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of activin type IB receptor signals in pancreatic β cells leads to defective insulin secretion through the attenuation of ATP-sensitive K+ channel activity.
    Nomura M; Morinaga H; Zhu HL; Wang L; Hasuzawa N; Takayanagi R; Teramoto N
    Biochem Biophys Res Commun; 2014 Jul; 450(1):440-6. PubMed ID: 24928396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
    Festa A; Williams K; Hanley AJ; Haffner SM
    Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pancreatic pacemaker out of rhythm. Disturbed pulsatile insulin release therapeutically interesting in type 2 diabetes].
    Sjöholm A
    Lakartidningen; 2007 Aug 8-21; 104(32-33):2228-9. PubMed ID: 17822199
    [No Abstract]   [Full Text] [Related]  

  • 32. Defective Amplifying Pathway of β-Cell Secretory Response to Glucose in Type 2 Diabetes: Integrated Modeling of In Vitro and In Vivo Evidence.
    Grespan E; Giorgino T; Arslanian S; Natali A; Ferrannini E; Mari A
    Diabetes; 2018 Mar; 67(3):496-506. PubMed ID: 29229615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-cell secretory dysfunction in the pathogenesis of low birth weight-associated diabetes: a murine model.
    Jimenez-Chillaron JC; Hernandez-Valencia M; Reamer C; Fisher S; Joszi A; Hirshman M; Oge A; Walrond S; Przybyla R; Boozer C; Goodyear LJ; Patti ME
    Diabetes; 2005 Mar; 54(3):702-11. PubMed ID: 15734846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2.
    Guillam MT; Hümmler E; Schaerer E; Yeh JI; Birnbaum MJ; Beermann F; Schmidt A; Dériaz N; Thorens B
    Nat Genet; 1997 Nov; 17(3):327-30. PubMed ID: 9354799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucocorticoids and beta-cell function.
    Fichna M; Fichna P
    Endokrynol Pol; 2017; 68(5):568-573. PubMed ID: 29168546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Islet defects and insulin resistance in models of obese non-insulin-dependent diabetes.
    Bailey CJ; Flatt PR
    Diabetes Metab Rev; 1993 Nov; 9 Suppl 1():43S-50S. PubMed ID: 8299488
    [No Abstract]   [Full Text] [Related]  

  • 37. Glucose uptake, utilization, and signaling in GLUT2-null islets.
    Guillam MT; Dupraz P; Thorens B
    Diabetes; 2000 Sep; 49(9):1485-91. PubMed ID: 10969832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adiponectin is functionally active in human islets but does not affect insulin secretory function or beta-cell lipoapoptosis.
    Staiger K; Stefan N; Staiger H; Brendel MD; Brandhorst D; Bretzel RG; Machicao F; Kellerer M; Stumvoll M; Fritsche A; Häring HU
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6707-13. PubMed ID: 16204361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular insights into insulin action and secretion.
    Rhodes CJ; White MF
    Eur J Clin Invest; 2002 Jun; 32 Suppl 3():3-13. PubMed ID: 12028370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta cell failure: causes and consequences.
    Kahn SE
    Int J Clin Pract Suppl; 2001 Sep; (123):13-8. PubMed ID: 11594291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.